Total Funding
31
10
Total FundingPost-IPO Equity raised
Growth Score 31 in past quarter
-2 pts
Heat Score 10 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
244972
H-CYTE operates at the intersection of science and wellness
- Tanya Rhodes: Chief Scientific Officer
- Jeremy Daniel: Chief Financial Officer
About the Company
H-CYTE is a biotechnology engineering institution that specializes in developing treatments for chronic diseases. The company is focused on developing cellular therapeutics to improve the health conditions of patients. The company aims to help improve the lives of patients through medical technology.